Paper22200728
The endothelin receptor antagonist bosentan improves peripheral endothelial function in patients with type 2 diabetes mellitus and microalbuminuria: a randomised trial.
Rafnsson A and 5 others. Diabetologia, 2012. Cited by 63 papers, by iCite.
Cite this record
ConductScience Library. The endothelin receptor antagonist bosentan improves peripheral endothelial function in patients with type 2 diabetes mellitus and microalbuminuria: a randomised trial. Papers, record 22200728. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/22200728
- Disease
- type 2 diabetes mellitus613 drugs
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Connected records2
Records in the library's other databases whose lists name this one, each read from that database's own release: up to 20 of each kind, the most connected first.
Topics21
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Albuminuria | Major topic |
| Antihypertensive Agents | Major topic |
| Diabetes Mellitus, Type 2 | Major topic |
| Diabetic Angiopathies | Major topic |
| Endothelin Receptor Antagonists | Major topic |
| Endothelium, Vascular | Major topic |
| Sulfonamides | Major topic |
| Aged | |
| Bosentan | |
| Brachial Artery | |
| Diabetic Nephropathies | |
| Double-Blind Method | |
| Female | |
| Humans | |
| Hyperemia | |
| Male | |
| Microvessels | |
| Middle Aged | |
| Peripheral Vascular Diseases | |
| Severity of Illness Index | |
| Vasodilation |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT01357109 | Effect of Bosentan on Endothelial Function in Patients With Type 2 Diabetes | Derived from the trial | Yes |
Source ClinicalTrials.gov
References26
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 10792555 | Adverse endothelial function and the insulin resistance syndrome. | J Intern Med | 2000 | https://conductscience.org/library/papers/10792555 | PubMed |
| 2 | 12453909 | Endothelin contributes to basal vascular tone and endothelial dysfunction in human obesity and type 2 diabetes. | Diabetes | 2002 | https://conductscience.org/library/papers/12453909 | PubMed |
| 3 | 18212505 | Endothelin-A receptor blockade increases nutritive skin capillary circulation in patients with type 2 diabetes and microangiopathy. | J Vasc Res | 2008 | https://conductscience.org/library/papers/18212505 | PubMed |
| 4 | 2198188 | Elevated plasma endothelin in patients with diabetes mellitus. | Diabetologia | 1990 | https://conductscience.org/library/papers/2198188 | PubMed |
| 5 | 20167702 | Avosentan for overt diabetic nephropathy. | J Am Soc Nephrol | 2010 | https://conductscience.org/library/papers/20167702 | PubMed |
| 6 | 11004428 | Possible pathophysiological mechanisms for diabetic angiopathy in type 2 diabetes. | J Diabetes Complications | 2000 | https://conductscience.org/library/papers/11004428 | PubMed |
| 7 | 18441323 | Cholesterol lowering is more important than pleiotropic effects of statins for endothelial function in patients with dysglycaemia and coronary artery disease. | Eur Heart J | 2008 | https://conductscience.org/library/papers/18441323 | PubMed |
| 8 | 20733096 | Long-term administration of endothelin receptor antagonist improves coronary endothelial function in patients with early atherosclerosis. | Circulation | 2010 | https://conductscience.org/library/papers/20733096 | PubMed |
| 9 | 17645585 | Endothelial dysfunction in insulin resistance and type 2 diabetes. | J Intern Med | 2007 | https://conductscience.org/library/papers/17645585 | PubMed |
| 10 | 1955098 | Prevalence of micro- and macroalbuminuria, arterial hypertension, retinopathy and large vessel disease in European type 2 (non-insulin-dependent) diabetic patients. | Diabetologia | 1991 | https://conductscience.org/library/papers/1955098 | PubMed |
| 11 | 7545695 | Altered relation between circulating levels of insulin-like growth factor-binding protein-1 and insulin in growth hormone-deficient patients and insulin-dependent diabetic patients compared to that in healthy subjects. | J Clin Endocrinol Metab | 1995 | https://conductscience.org/library/papers/7545695 | PubMed |
| 12 | 12767662 | Enhanced external counterpulsation improves endothelial function in patients with symptomatic coronary artery disease. | J Am Coll Cardiol | 2003 | https://conductscience.org/library/papers/12767662 | PubMed |
| 13 | 17179929 | Mechanisms of Disease: endothelial dysfunction in insulin resistance and diabetes. | Nat Clin Pract Endocrinol Metab | 2007 | https://conductscience.org/library/papers/17179929 | PubMed |
| 14 | 11869173 | Endothelin-1 inhibits endothelium-dependent vasodilatation in the human forearm: reversal by ETA receptor blockade in patients with atherosclerosis. | Clin Sci (Lond) | 2002 | https://conductscience.org/library/papers/11869173 | PubMed |
| 15 | 16614356 | Role of nitric oxide in the regulation of digital pulse volume amplitude in humans. | J Appl Physiol (1985) | 2006 | https://conductscience.org/library/papers/16614356 | PubMed |
| 16 | 21263120 | Relation of brachial and digital measures of vascular function in the community: the Framingham heart study. | Hypertension | 2011 | https://conductscience.org/library/papers/21263120 | PubMed |
| 17 | 14693683 | Nitric oxide mediates protective effect of endothelin receptor antagonism during myocardial ischemia and reperfusion. | Am J Physiol Heart Circ Physiol | 2004 | https://conductscience.org/library/papers/14693683 | PubMed |
| 18 | 20181680 | Assessment of endothelial function by non-invasive peripheral arterial tonometry predicts late cardiovascular adverse events. | Eur Heart J | 2010 | https://conductscience.org/library/papers/20181680 | PubMed |
| 19 | 18458169 | Cross-sectional relations of digital vascular function to cardiovascular risk factors in the Framingham Heart Study. | Circulation | 2008 | https://conductscience.org/library/papers/18458169 | PubMed |
| 20 | 16633080 | Enhanced endothelium-dependent vasodilatation by dual endothelin receptor blockade in individuals with insulin resistance. | J Cardiovasc Pharmacol | 2006 | https://conductscience.org/library/papers/16633080 | PubMed |
Cited by33
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 63 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41139358 | Overexpression of miR-454-3p inhibits high glucose-induced ET-1 expression, leading to eNOS upregulation in endothelial cells: an integrated bioinformatics and experimental analysis. | Hum Cell | 2025 | https://conductscience.org/library/papers/41139358 | PubMed |
| 40978470 | G protein-coupled receptor-mediated renal fibrosis: a key focus on kidney disease drug development. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/40978470 | PubMed |
| 40722116 | Type II diabetes in systemic sclerosis patients: insights from an observational, multicenter study of GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale). | Arthritis Res Ther | 2025 | https://conductscience.org/library/papers/40722116 | PubMed |
| 40469998 | Endothelial dysfunction in single ventricle physiology and the Fontan circulation - What lies ahead. | Int J Cardiol Congenit Heart Dis | 2025 | https://conductscience.org/library/papers/40469998 | PubMed |
| 40203840 | Dual ETA-ETB receptor antagonism improves metabolic syndrome-induced heart failure with preserved ejection fraction. | Fundam Clin Pharmacol | 2025 | https://conductscience.org/library/papers/40203840 | PubMed |
| 40015728 | The role of endothelin receptor antagonists in kidney disease. | Ren Fail | 2025 | https://conductscience.org/library/papers/40015728 | PubMed |
| 37455912 | Epigenetic modification in diabetic kidney disease. | Front Endocrinol (Lausanne) | 2023 | https://conductscience.org/library/papers/37455912 | PubMed |
| 35977903 | Advances in the management of diabetic kidney disease: beyond sodium-glucose co-transporter 2 inhibitors. | Kidney Res Clin Pract | 2022 | https://conductscience.org/library/papers/35977903 | PubMed |
| 35861844 | Association of the Coexistence of Somnipathy and Diabetes With the Risks of Cardiovascular Disease Events, Stroke, and All-Cause Mortality: A Systematic Review and Meta-analysis. | J Am Heart Assoc | 2022 | https://conductscience.org/library/papers/35861844 | PubMed |
| 35317812 | Endothelial dysfunction and altered endothelial biomarkers in patients with post-COVID-19 syndrome and chronic fatigue syndrome (ME/CFS). | J Transl Med | 2022 | https://conductscience.org/library/papers/35317812 | PubMed |
| 35194565 | Erythrocytes Induce Vascular Dysfunction in COVID-19. | JACC Basic Transl Sci | 2022 | https://conductscience.org/library/papers/35194565 | PubMed |
| 34909290 | Endothelin Receptor Antagonists as a Potential Treatment of Diabetic Nephropathy: A Systematic Review. | Cureus | 2021 | https://conductscience.org/library/papers/34909290 | PubMed |
| 33269066 | Endothelin receptor antagonists for the treatment of diabetic nephropathy: A meta-analysis and systematic review. | World J Diabetes | 2020 | https://conductscience.org/library/papers/33269066 | PubMed |
| 32627269 | Endothelin-1 in the pathophysiology of obesity and insulin resistance. | Obes Rev | 2020 | https://conductscience.org/library/papers/32627269 | PubMed |
| 31460491 | Digital ulcers in systemic sclerosis and insulin-dependent diabetes mellitus type 2. | Rheumatol Adv Pract | 2019 | https://conductscience.org/library/papers/31460491 | PubMed |
| 31177906 | Endothelin Receptor Antagonism Improves Lipid Profiles and Lowers PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) in Patients With Chronic Kidney Disease. | Hypertension | 2019 | https://conductscience.org/library/papers/31177906 | PubMed |
| 29707151 | High levels of circulating endothelial progenitor cells in patients with diabetic retinopathy are positively associated with ARHGAP22 expression. | Oncotarget | 2018 | https://conductscience.org/library/papers/29707151 | PubMed |
| 29468936 | COPD as an endothelial disorder: endothelial injury linking lesions in the lungs and other organs? (2017 Grover Conference Series). | Pulm Circ | 2018 | https://conductscience.org/library/papers/29468936 | PubMed |
| 28327146 | Association between obstructive sleep apnea severity and endothelial dysfunction in patients with type 2 diabetes. | Cardiovasc Diabetol | 2017 | https://conductscience.org/library/papers/28327146 | PubMed |
| 27492897 | Targeting the ROS-HIF-1-endothelin axis as a therapeutic approach for the treatment of obstructive sleep apnea-related cardiovascular complications. | Pharmacol Ther | 2016 | https://conductscience.org/library/papers/27492897 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| EDN1 | 1906 | PubTator's text mining | https://conductscience.org/library/genes/1906 |
Source NCBI Gene
Drugs1
The drugs whose trials, in the Pipelines release, list the paper.
| Drug | ChEMBL ID | The trials list it as | Trials | In Drugs and targets |
|---|---|---|---|---|
| BOSENTAN | CHEMBL957 | Derived from the trial | 1 | https://conductscience.org/library/drugs/CHEMBL957 |
Source ChEMBL
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/22200728
GET https://conductscience.org/api/papers/v1/22200728/references?page=2